Dr. Hossein Ghofrani MD
Physician, JUSTUS-LIEBIG-UNIVERSITAET GIESSEN
Member of the Healthcare Council
Council Member Biography
Hossein Ardeschir (Ardi) Ghofrani, MD, is Lead physician of the Pulmonary Hypertension Centre at the University of Giessen Lung Center (UGLC), Germany. Prof. Ghofrani is a Reviewer for various high impact scientific journals including Lancet, AJRCCM, Circulation, and Circulation research amongst others. He is member of the steering comittee of the excellence cluster cardiopulmonary research (ECCPS). Dr. Ghofrani is a Member of several scientific advisory boards for pharmaceutical companies, including Pfizer, Actelion, Encysive, Ergonex, and Bayer-Schering AG. He has contributed to several publications on the topic of pulmonary hypertension. Prof. Ghofrani has been engaged in the development of new drugs for the treatment of pulmonary hypertension such as sildenafil, bosentan, sitaxentan, inh. iloprost and treprostinil, ambrisentan, and imatinib. (This is me - Update Profile)
Employment History
- 2005 - Unspecified
- Physician, JUSTUS-LIEBIG-UNIVERSITAET GIESSEN
GLG NewsSM Analyses by Hossein Ghofrani(?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Hossein Ghofrani has not published any GLG News Analyses.
Leading institutions connect with Hossein Ghofrani through GLG
GLG Study Groups with Hossein Ghofrani(?)
| Study Group Name | No. Members |
|---|---|
| Physicians (Germany) | 1172 |
| Pulmonologists (EU) | 244 |
| Physicians who Treat COPD (EU) | 107 |
| Lipitor Prescribers: Internal Medicine Physicians | 62 |
| Internal Medicine Physicians who Treat Primary Pulmonary Hypertension (EU) | 24 |
GLG Live Meetings with Hossein Ghofrani(?)
Hossein Ghofrani has not participated in any GLG Live Meetings.